Abstract
BackgroundMany combination immunotherapies have been investigated however identifying subsets of patients who will benefit from each combination has been challenging. While immunotherapy combinations have to date centered on therapeutic targets...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
